Multidisciplinary management of patients with post-Covid syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients experiencing persistent symptoms following SARS-CoV2 infection, known as post-Covid syndrome. It aims to create a clinical database to better understand these complex cases and identify blood markers that could predict the disease's progression and inform treatment strategies. The study includes both retrospective and prospective cohorts of patients who have been referred for multidisciplinary care. By analyzing the data collected, the research seeks to enhance the management of post-Covid symptoms and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

All patients who have joined the Epsilon care pathway since its opening in February 2022, i.e.:

* Patients with post-Covid syndrome referred to the Epsilon sector from the city medicine:
* Patient with documented SARS-Cov2 pneumonia
* With persistent and severe symptoms beyond 4 weeks or complex or disabling symptoms beyond 3 months
* Patient over 18 years old.

Post-hospital sector:

* Patient with documented SARS-Cov2 pneumonia
* Hospitalized for oxygen therapy (at least 48h)
* Not having a referring pulmonologist
* Not institutionalized
* With a life expectancy of more than 6 months.

Exclusion Criteria:

* Patient refusing that this data to be used for research purposes (objection form).
* Patient with untreated comorbidities

Where it's running

• Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon
  Pierre-Bénite, France Recruiting

Study contacts

• Principal investigator: Sébastien COURAUD, Pr — Department of Acute Pneumology and Thoracic Oncology, Hôpital Lyon Sud, Hospices Civils de Lyon
• Study coordinator: Sébastien COURAUD, Pr
• Email: Sebastien.couraud@chu-lyon.fr
• Phone: +33 (0)4 78 86 44 01

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Immunoadsorption blood filter for autoimmune long COVID

  We will test a blood-filter treatment called immunoadsorption in people with long COVID who have specific autoantibodies to see if their fatigue and daily functioning get better.

  Recruiting Phase 2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07316127

• Cold water hydrotherapy to support rehabilitation in Post-COVID Syndrome

  This tests whether adding cold water hydrotherapy to standard rehabilitation helps people with Post-COVID Syndrome improve their quality of life.

  Recruiting Schön Klinik Berchtesgadener Land · Schönau am Königssee, Bavaria · NCT07013903

• Rehabilitation program to reduce fatigue after COVID-19

  This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06156176

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.